The Pathogenesis and Prognostic Factors of Lymphoma

Abroad (travel likely)Recruiting

Conditions

Lymphoma · Hodgkin Lymphoma · Non-hodgkin Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Zhongshan Hospital，Fudan University, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Peng Liu, Ph.D) · liu.peng@zs-hospital.sh.cn · +862164041990
Contact: Principal Investigator (Peng Liu, Ph.D)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma

Lymphoma

Abroad (travel likely)RecruitingPHASE2

Houston, United States

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

Diffuse Large Cell Lymphoma · Non-Hodgkin Lymphoma · Burkitt Lymphoma

Abroad (travel likely)RecruitingPHASE1

Bethesda, United States

A Cognitive Training Intervention for Improving Cognitive and Neurological Outcomes in Patients Undergoing Treatment for Relapsed or Refractory Multiple Myeloma or B-cell Non-Hodgkin Lymphoma

Recurrent B-Cell Non-Hodgkin Lymphoma · Recurrent Multiple Myeloma · Refractory B-Cell Non-Hodgkin Lymphoma

Abroad (travel likely)Recruiting

Columbus, United States

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

Follicular Lymphoma · Lymphoma

Abroad (travel likely)RecruitingPHASE2

Washington D.C., United States · Basking Ridge, United States